Another deleterious mutation of DLBCL cells that can cause failure to activate immune cells is a loss of CD70, which would normally bind to CD27 on the CD4+ and/or CD8+ T cells to cause activation. Here, CD8A is linked to diffuse large B-cell lymphoma.